AstraZeneca Inks $1.92 Billion Licensing Deal with HK-listed CSPC to Boost Cardiovascular Pipeline
On Monday, AstraZeneca (NASDAQ: AZN) said it would pay up to $1.92 billion to CSPC Pharmaceutical Group Ltd in an […]
On Monday, AstraZeneca (NASDAQ: AZN) said it would pay up to $1.92 billion to CSPC Pharmaceutical Group Ltd in an […]